c="carboxy-terminal truncation" 1:1 1:2||t="problem"||cui="C1706395"||tot="Protein Truncation Abnormality"||ns="-827"
c="human alpha-galactosidase A" 1:4 1:6||t="medication"||cui="C0002268"||tot="Alpha-galactosidase"||ns="-694"
c="Fabry disease" 1:12 1:13||t="problem"||cui="C0002986"||tot="Fabry Disease"||ns="-1000"
c="Fabry disease" 2:0 2:1||t="problem"||cui="C0002986"||tot="Fabry Disease"||ns="-1000"
c="X-linked disorder" 2:4 2:5||t="problem"||cui="C0012634"||tot="Disease"||ns="-827"
c="alpha-galactosidase A" 2:14 2:15||t="medication"||cui="C0002268"||tot="Alpha-galactosidase"||ns="-734"
c="Fabry disease" 2:31 2:32||t="problem"||cui="C0002986"||tot="Fabry Disease"||ns="-1000"
c="tyrosine" 2:36 2:36||t="medication"||cui="C0041485"||tot="Tyrosine"||ns="-1000"
